As Treatments Get Cancelled Because of COVID-19, Patients Worry About Adequacy of Care

Your gift is doubled through December 31.

Donate Now

“How people are treated in the adjuvant setting is supposedly based on high-level clinical trials, results of those trials, results of high-level evidence. That’s what we’re told,” Fran Visco, president of the National Breast Cancer Coalition, said to The Cancer Letter.

Related News